• news.cision.com/
  • Vigmed/
  • Vigmed announces a rights issue of approximately SEK 56.4 million. The rights issue is fully guaranteed
English

Vigmed announces a rights issue of approximately SEK 56.4 million. The rights issue is fully guaranteed

Report this content

For further information pls visit:

https://www.vigmed.com/investor/rights-issue-2014.aspx

For further information contact:

Chairman of the board, Lennart Holm 46 70 630 8562 or CEO, Finn Ketler 46 42 600 5311

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.


Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com/investor

Documents & Links